Short answer
A gut diversity score is a summary metric that tries to describe how varied the microbes in a stool sample appear. That can be useful for education or trend tracking, but it is not a diagnosis. The score depends on the lab method, the company’s database, diet, medications, illness, and how the result is normalized.
What the score may summarize
| Report term | Plain-English meaning | Limit |
|---|---|---|
| Alpha diversity | Diversity within one sample. | Does not identify a disease by itself. |
| Beta diversity | How one sample differs from other samples. | Depends on the comparison database and method. |
| Richness | How many types of organisms are detected. | More types is not automatically better in every context. |
| Evenness | How balanced the detected organisms appear. | Can shift with diet, antibiotics, illness, and sample timing. |
Why scores change
NIH resources describe the microbiome as complex and dynamic. Stool samples are useful and accessible, but they do not fully represent every part of the gut. Scores can move because of diet changes, recent antibiotics, illness, travel, bowel habit changes, shipping conditions, or a new company algorithm.
- Different companies may use different sequencing or scoring approaches.
- One sample does not tell you whether a difference is durable or clinically important.
- Medication and diet changes can shift the score without proving better health.
When comparison may help
Repeating the same test from the same company can be reasonable if you are tracking a specific intervention and you know what change would matter. The repeat result is most useful when it answers a practical question, such as whether a clinician-directed diet or antibiotic plan changed symptoms or a validated marker.
When symptoms matter more
A diversity score should not delay medical evaluation. Persistent diarrhea, weight loss, blood in the stool, fever, dehydration, severe abdominal pain, or worsening symptoms need a medical workup instead of another wellness score.
- Microbiome reports do not rule out infection, inflammatory bowel disease, celiac disease, or another urgent cause.
- Travel history, antibiotic use, immune status, and stool pattern often matter more than a score alone.
- A medical stool test is better when the question is diagnosis, not curiosity.
Questions to ask
- What exact diversity metric is reported?
- What reference population is my sample compared with?
- Does the company show repeatability if the same person tests twice?
- Does the report distinguish research association from medical action?
- Would symptoms be better evaluated with a medical stool test?
Related guides: microbiome testing, stool test vs microbiome test, microbiome retesting intervals, and probiotics and test-based recommendations.
FAQ
Does a gut diversity score diagnose disease?
No. A gut diversity score is a summary metric, not a diagnosis. It can help with learning or trend tracking, but it does not tell you by itself whether you have IBS, infection, celiac disease, inflammation, or another condition.
Is a higher score always better?
Not always. Diversity is only one part of the report, and more diversity does not automatically mean better symptoms, better health, or lower disease risk.
Why can my score change between tests?
Diet, antibiotics, illness, travel, bowel habits, sample timing, shipping, and the company’s algorithm can all change the result.
Can I compare scores across different companies?
Usually not very well. Different labs may use different methods, reference groups, and scoring formulas, so a number from one company may not mean the same thing as a number from another.
When is retesting useful?
Retesting is most useful when you are tracking a specific change and the same lab is using the same method over time. Without a decision tied to the repeat result, retesting can just measure normal variation.
When should symptoms matter more than the score?
If you have persistent diarrhea, blood in the stool, weight loss, fever, dehydration, severe pain, or symptoms that are worsening, a medical stool test or clinician-directed evaluation matters more than a diversity score.